Featured Stories

Rethinking the Role of the CRO in Drug Discovery


Nature spoke with Emily Hickey, Corporate Senior VP of Global Discovery, about our mission to deliver quality science to our partners while making the drug discovery ecosystem easier to navigate. 

Charles River Presents 25 Posters at Neuroscience 2015


Neuroscience 2015 offered our experts the opportunity to collaborate with top scientists from across the globe as we work to advance research in this rapidly transforming field. During this year’s meeting, our team of leading Central Nervous System (CNS) researchers presented, either independently or in conjunction with our clients, 25 posters to showcase our latest research findings.

Audit Success Demonstrates Our Commitment to Quality


In addition to visits from our clients’ auditors, we are regularly inspected by all major regulatory authorities. So far in 2015, we have been audited by several global regulatory authorities, including the FDA and AAALAC.

Expanded Zebrafish PCR Testing


The 360 Diagnostics™ R&D team recently completed the validation of new PCR assays for infectious diseases that commonly affect zebrafish colonies. 

Displaying results 1-10 (of 197)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >|